Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Fusion Rate With K2M VESUVIUS® Demineralized Fibers Used With K2M EVEREST® Spinal System Compared to Autologous Bone Graft With Posterior Stabilization

NCT02064855 is registered in ClinicalTrials.gov with K2M, Inc. as lead sponsor.

NCT NCT02064855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02064855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Fusion Rate With K2M VESUVIUS® Demineralized Fibers Used With K2M EVEREST® Spinal System Compared to Autologous Bone Graft With Posterior Stabilization
Lead sponsor
K2M, Inc.
Phase
Observational
Overall status
Terminated
Start date
August 31, 2014
Completion date
December 12, 2019
Enrollment
108 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, spinal stenosis, spondylolisthesis